A Delphi consensus study on oral language disorder in Spanish-speaking countries
Abstract
Oral language acquisition disorder is highly prevalent and can lead to severe and persistent difficulties throughout the lifespan. The aim of this study was to reach a consensus within the Spanish-speaking context on conceptual, classificatory, and diagnostic aspects of oral language disorder, given the existing variability in terminology and clinical criteria. To this end, a panel of 51 specialists from different Spanish-speaking countries participated in a two-round Delphi study. In the first round, 28 questions addressing terminology, subtypes, comorbidities, and diagnosis were evaluated; in the second round, 12 statements were reformulated based on the previous results. This process led to the establishment of 25 main agreements. At the terminological level, consensus was reached on the use of the term “language disorder” to refer to persistent difficulties affecting communicative development, and “developmental language disorder (DLD)” when no identifiable biomedical cause is present. The creation of formal subtypes was rejected, and a detailed description of the affected linguistic domains was recommended. It was also agreed that certain biomedical conditions exclude a diagnosis of DLD, although DLD may co-occur with other disorders. Regarding diagnosis, the need for a comprehensive, multidimensional assessment based on clinical and functional criteria was emphasized, allowing the identification of severe and persistent difficulties from four years of age onwards. These agreements represent a significant step toward the unification of criteria in the Spanish-speaking field.
Format
License
In order to support the global exchange of knowledge, the journal Revista de Investigación en Logopedia is allowing unrestricted access to its content as from its publication in this electronic edition, and as such it is an open-access journal. The originals published in this journal are the property of the Complutense University of Madrid and any reproduction thereof in full or in part must cite the source. All content is distributed under a Creative Commons Attribution 4.0 use and distribution licence (CC BY 4.0). This circumstance must be expressly stated in these terms where necessary. You can view the summary and the complete legal text of the licence.






